Extract of medicinal plant Artemisia annua interferes with replication of SARS-CoV-2 in vitro

Researchers in the United States have shown that extracts of an aromatic herb called Artemisia annua inhibit the replication of severe acute respiratory coronavirus (SARS-CoV-2) – the agent responsible for the current coronavirus disease 2019 (COVID-19) pandemic.

IJMS, Free Full-Text

Antiviral, virucidal and antioxidant properties of Artemisia annua against SARS-CoV-2 - ScienceDirect

Advances in natural product anti-coronavirus research (2002-2022), Chinese Medicine

Full article: Prevention, treatment and potential mechanism of herbal medicine for Corona viruses: A review

Medicinal Plants as COVID-19 Remedy

Coronavirus: What do we know about the artemisia plant? - BBC News

Ethanolic extract of Artemisia campestris subsp. glutinosa (Besser) Batt. inhibits HIV–1 replication in vitro through the activity of terpenes and flavonoids on viral entry and NF–κB pathway - ScienceDirect

SARS-CoV-2 omicron variants are susceptible in vitro to Artemisia annua hot water extracts - ScienceDirect

Dihydroartemisinin-Ursodeoxycholic Bile Acid Hybrids in the Fight against SARS-CoV-2

Saponin and Immune Stimulant Based Gargles and Nasal Rinses: A Potential Virucidal for Preventive Management of SARS-CoV-2 Infection?

Artemisia annua L. and Its Derivatives: Their Antiviral Effects on COVID-19 and Possible Mechanisms

Friend or Foe? Implication of the autophagy-lysosome pathway in SARS-CoV-2 infection and COVID-19

Antiviral, virucidal and antioxidant properties of Artemisia annua against SARS-CoV-2 - ScienceDirect

Artemisia and Artemisia-based products for COVID-19 management: current state and future perspective

Instant determination of the artemisinin from various Artemisia annua L. extracts by LC‐ESI‐MS/MS and their in‐silico modelling and in vitro antiviral activity studies against SARS‐CoV‐2 - Dogan - 2022 - Phytochemical Analysis